ArticleCellular & molecular immunology2026

YDJC restrains Th1 cell differentiation by blocking SREBP2-mediated cholesterol biosynthesis to alleviate mucosal inflammation in inflammatory bowel disease.

Ai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.